RxDoctor Payments Data

Linda Hagins

Family · Americus, GANPI 1760588743

Payments from drug & device makers

$1,370in general payments, 2019–2025

Across 76 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$460
  • GSK$311
  • AbbVie$174
  • AstraZeneca$125
  • Pfizer$74
  • Boehringer Ingelheim$55
  • plus $171 from 8 others

What the payments were for

  • Food & beverage$1,370100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,370 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$52,303
Medicare patients
126
Services billed
1,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban43$39,013
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$35,617
OzempicSemaglutide37$35,346
JardianceEmpagliflozin22$20,892
LinzessLinaclotide23$20,628
FarxigaDapagliflozin Propanediol11$17,537
MyrbetriqMirabegron11$10,304
SymbicortBudesonide/Formoterol Fumarate21$4,857
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$4,149
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate14$2,727
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,710
Levothyroxine Sodium151$1,928
Omeprazole133$1,911
Fluticasone Propionate185$1,770
Albuterol Sulfate HfaAlbuterol Sulfate78$1,684

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$74$39,01343 claims
GSKTrelegy Ellipta, Shingrix$311$38,32760 claims
Novo NordiskOzempic$460$35,34637 claims
AstraZenecaFarxiga, Symbicort$125$22,39432 claims
Boehringer IngelheimJardiance$55$20,89222 claims
AbbVieLinzess$174$20,62823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.

Other family in Americus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →